Abstract:Despite the decline in their proliferative potential, senescent cells display a high metabolic activity. Senescent cells have been shown to acquire a more glycolytic state even in presence of high oxygen levels, in a way similar to cancer cells. The diversion of pyruvate, the final product of glycolysis, away from oxidative phosphorylation results in an altered bioenergetic state and may occur as a response to the enhanced oxidative stress caused by the accumulation of dysfunctional mitochondria. This metabolic shift leads to increased AMP/ATP and ADP/ATP ratios, to the subsequent AMPK activation, and ultimately to p53-mediated growth arrest. Mounting evidences suggest that metabolic reprogramming is critical to direct considerable amounts of energy toward specific activities related to the senescent state, including the senescence-associated secretory phenotype (SASP) and the modulation of immune responses within senescent cell tissue microenvironment. Interestingly, despite the relative abundance of oxygen in the vascular compartment, healthy endothelial cells (ECs) produce most of their ATP content from the anaerobic conversion of glucose to lactate. Their high glycolytic rate further increases during senescence. Alterations in EC metabolism have been identified in age-related diseases (ARDs) associated with a dysfunctional vasculature, including atherosclerosis, type 2 diabetes and cardiovascular diseases. In particular, higher production of reactive oxygen species deriving from a variety of enzymatic sources, including uncoupled endothelial nitric oxide synthase and the electron transport chain, causes DNA damage and activates the NAD+-consuming enzymes polyADP-ribose polymerase 1 (PARP1). These non-physiological mechanisms drive the impairment of the glycolytic flux and the diversion of glycolytic intermediates into many pathological pathways. Of note, accumulation of senescent ECs has been reported in the context of ARDs. Through their pro-oxidant, pro-inflammatory, vasoconstrictor, and prothrombotic activities, they negatively impact on vascular physiology, promoting both the onset and development of ARDs. Here, we review the current knowledge on the cellular senescence-related metabolic changes and their contribution to the mechanisms underlying the pathogenesis of ARDs, with a particular focus on ECs. Moreover, current and potential interventions aimed at modulating EC metabolism, in order to prevent or delay ARD onset, will be discussed.

Mechanisms and metabolic consequences of adipocyte progenitor replicative senescence

The impact of cellular senescence in human adipose tissue

Physiological Approaches Targeting Cellular and Mitochondrial Pathways Underlying Adipose Organ Senescence

Adipose tissue senescence: Biological changes, hallmarks and therapeutic approaches

Targeting cellular senescence in metabolic disease

Adipose tissue aging: mechanisms and therapeutic implications

Cellular senescence and its role in white adipose tissue

Targeting senescent cells alleviates obesity-induced metabolic dysfunction

Adipose Tissue Aging and Metabolic Dysfunction

Age-dependent genes in adipose stem and precursor cells affect regulation of fat cell differentiation and link aging to obesity via cellular and genetic interactions

M2 macrophage-derived TGF-β induces age-associated loss of adipogenesis through progenitor cell senescence

Aging in adipocytes: potential impact of inherent, depot-specific mechanisms

Enhancing adipose tissue functionality in obesity: senotherapeutics, autophagy and cellular senescence as a target

Research Advances in Adipose Tissue Aging Related Cytological Changes and Molecular

Cellular Senescence and Extracellular Vesicles in the Pathogenesis and Treatment of Obesity-A Narrative Review

Adipose tissue microenvironments during aging: Effects on stimulated lipolysis

Adipose tissue as a linchpin of organismal ageing

Thermogenic adipose tissue aging: Mechanisms and implications

Where Metabolism Meets Senescence: Focus on Endothelial Cells

Cellular and Molecular Implications of Mature Adipocyte Dedifferentiation.

Systems biology of adipose tissue metabolism: regulation of growth, signaling and inflammation